Infection and mortality trend of COVID-19 over the years in India and measures taken to curb the epidemic: a comprehensive review

Authors

  • Priyadarshini Gupta School of Biotechnology and Bioinformatics, DY Patil Deemed to be University
  • Riya Singh School of Biotechnology and Bioinformatics, DY Patil Deemed to be University
  • Prerona Boruah School of Biotechnology and Bioinformatics, DY Patil Deemed to be University https://orcid.org/0000-0001-8280-0906
  • Mala Parab School of Biotechnology and Bioinformatics, DY Patil Deemed to be University
  • PramodKumar P Gupta School of Biotechnology and Bioinformatics, DY Patil Deemed to be University
  • Pranita Thakur School of Biotechnology and Bioinformatics, DY Patil Deemed to be University, Navi Mumbai, India
  • Mary David School of Biotechnology and Bioinformatics, DY Patil Deemed to be University, Navi Mumbai, India

Keywords:

Covid 19, India, Pandemic, Comorbidities, Virus, Variants

Abstract

Background and Aims: The trend of COVID-19 infections in India has been dynamic as well as complex, with several peaks and troughs since the pandemic began, including the rise of advanced and more contagious variants of the virus, increased public complacency towards health guidelines, and the challenges posed by vaccine hesitancy and misinformation. The current article comprehends the patterns of COVID-19 infection in India, with highlights of infection patterns and mortality in several states.
Methods: With the use of keywords, we looked through the National Library of Medicine, Google Scholar, and PubMed electronic databases. We have all the specific information from the case reports and clinical series of the patients from the various COVID-19 pandemic waves in India. In order to assess the national impact of these epidemic waves, we then carefully review the case reports.

References

C. R. MacIntyre, “Global spread of COVID-19 and pandemic potential,” Global Biosecurity, vol. 1, no. 3, Feb. 2020, doi: 10.31646/gbio.55.

M. Andrews et al., “First confirmed case of COVID-19 infection in India: A case report,” Indian Journal of Medical Research, vol. 151, no. 5, p. 490, 2020, doi: 10.4103/ijmr.IJMR_2131_20.

Y. Assefa, C. F. Gilks, S. Reid, R. van de Pas, D. G. Gete, and W. van Damme, “Analysis of the COVID-19 pandemic: lessons towards a more effective response to public health emergencies,” Global Health, vol. 18, no. 1, p. 10, Feb. 2022, doi: 10.1186/s12992-022-00805-9.

N. Purohit, Y. Chugh, P. Bahuguna, and S. Prinja, “COVID-19 management: The vaccination drive in India,” Health Policy Technol, vol. 11, no. 2, p. 100636, Jun. 2022, doi: 10.1016/j.hlpt.2022.100636.

P. Mahajan and J. Kaushal, “Epidemic Trend of COVID-19 Transmission in India During Lockdown-1 Phase,” J Community Health, vol. 45, no. 6, pp. 1291–1300, Dec. 2020, doi: 10.1007/s10900-020-00863-3.

“COVID19 STATEWISE STATUS,” mygov.in. Feb. 15, 2023.

Z. Siddiqi et al., “Prevalence of Comorbidities in Survivors and Non-Survivors of Severe COVID-19 at a Dedicated COVID Care Centre,” Journal of The Association of Physicians of India, vol. 70, Jan. 2022.

P. Shil, N. M. Atre, and B. v Tandale, “Epidemiological findings for the first and second waves of COVID-19 pandemic in Maharashtra, India,” Spat Spatiotemporal Epidemiol, vol. 41, p. 100507, Jun. 2022, doi: 10.1016/j.sste.2022.100507.

P. Bogam et al., “Burden of COVID-19 and case fatality rate in Pune, India: an analysis of the first and second wave of the pandemic,” IJID Regions, vol. 2, pp. 74–81, Mar. 2022, doi: 10.1016/j.ijregi.2021.12.006.

K. Zaman et al., “Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India,” Front Med (Lausanne), vol. 9, Nov. 2022, doi: 10.3389/fmed.2022.955930.

A. Bhattachyra, “Covid-19: Second wave cases cross 2cr, nearly 2/3rd of total infection,” The times of India, new delhi, Jul. 19, 2021.

A. BHATTACHARYA, “India’s Covid toll in 2nd wave tops 2.5 lakh, 1 lakh more deaths than in 1st wave,” THE TIMES OF INDIA, NEW DELHI, Jul. 14, 2021.

P. Ranganathan et al., “The Second- vs First-wave COVID-19: More of the Same or a Lot Worse? A Comparison of Mortality between the Two Waves in Patients Admitted to Intensive Care Units in Nine Hospitals in Western Maharashtra,” Indian Journal of Critical Care Medicine, vol. 25, no. 12, pp. 1343–1348, Dec. 2021, doi: 10.5005/jp-journals-10071-24042.

D. Duong, “Alpha, Beta, Delta, Gamma: What’s important to know about SARS-CoV-2 variants of concern?,” Can Med Assoc J, vol. 193, no. 27, pp. E1059–E1060, Jul. 2021, doi: 10.1503/cmaj.1095949.

S. Kunal, Aditi, K. Gupta, and P. Ish, “COVID-19 variants in India: Potential role in second wave and impact on vaccination,” Heart & Lung, vol. 50, no. 6, pp. 784–787, Nov. 2021, doi: 10.1016/j.hrtlng.2021.05.008.

K. Hayawi, S. Shahriar, M. A. Serhani, H. Alashwal, and M. M. Masud, “Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review,” Vaccines (Basel), vol. 9, no. 11, p. 1305, Nov. 2021, doi: 10.3390/vaccines9111305.

“Gamma (P.1),” Global Virus Network, 2021.

GISAID, “Tracking of hCoV-19 Variants,” GISAID.

L. Lin, Y. Liu, X. Tang, and D. He, “The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern,” Front Public Health, vol. 9, Nov. 2021, doi: 10.3389/fpubh.2021.775224.

A. K. Singh, R. Singh, S. R. Joshi, and A. Misra, “Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 15, no. 4, p. 102146, Jul. 2021, doi: 10.1016/j.dsx.2021.05.019.

G. Kumar et al., “Clinical profile of hospitalized COVID-19 patients in first & second wave of the pandemic: Insights from an Indian registry based observational study,” Indian Journal of Medical Research, vol. 153, no. 5, p. 619, 2021, doi: 10.4103/ijmr.ijmr_1628_21.

V. B. Kute et al., “Consequences of the first and second COVID ‐19 wave on kidney transplant recipients at a large Indian transplant centre,” Nephrology, vol. 27, no. 2, pp. 195–207, Feb. 2022, doi: 10.1111/nep.13961.

J. S. Sundarakumar, A. L. Menesgere, S. K. S. Hameed, and V. Ravindranath, “Depression and anxiety during the first and second waves of the COVID‐19 pandemic in two large, prospective, aging cohorts in rural and urban India,” Health Sci Rep, vol. 5, no. 6, Nov. 2022, doi: 10.1002/hsr2.901.

“COVID-19 pandemic death rates by country,” Wikipedia.

H. Mander, “How many Indians actually died during the second Covid-19 wave?,” scroll.in, Feb. 27, 2022.

M. of S. and T. G. of I. Department of Biotechnology, “Announcement,” Indian SARS-COV-2 Genomics Consortium. Jul. 11, 2022.

A. K. Singh and A. Misra, “Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 14, no. 6, pp. 1625–1630, Nov. 2020, doi: 10.1016/j.dsx.2020.08.032.

K. Singh, A. Verma, and M. Lakshminarayan, “India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review,” Osong Public Health Res Perspect, vol. 13, no. 5, pp. 316–327, Oct. 2022, doi: 10.24171/j.phrp.2022.0104.

Downloads

Published

12.06.2023

Issue

Vol. 1 No. 1 (2023)

Section

Reviews

License

Copyright (c) 2023 Priyadarshini Gupta, Riya Singh, Prerona Boruah, Mala Parab, PramodKumar P Gupta, Pranita Thakur, Mary David

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.